Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Non-Coding RNA Networks in ALK-Positive Anaplastic-Large Cell Lymphoma.

Fuchs S, Naderi J, Meggetto F.

Int J Mol Sci. 2019 Apr 30;20(9). pii: E2150. doi: 10.3390/ijms20092150. Review.

2.

miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.

Hoareau-Aveilla C, Quelen C, Congras A, Caillet N, Labourdette D, Dozier C, Brousset P, Lamant L, Meggetto F.

Haematologica. 2019 Feb;104(2):347-359. doi: 10.3324/haematol.2018.195131. Epub 2018 Sep 27.

3.

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.

Congras A, Caillet N, Torossian N, Quelen C, Daugrois C, Brousset P, Lamant L, Meggetto F, Hoareau-Aveilla C.

Oncotarget. 2018 Feb 8;9(18):14539-14551. doi: 10.18632/oncotarget.24465. eCollection 2018 Mar 6.

4.

Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive Lymphomas.

Hoareau-Aveilla C, Meggetto F.

Cancers (Basel). 2017 Aug 3;9(8). pii: E100. doi: 10.3390/cancers9080100. Review.

5.

Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma.

Mitou G, Frentzel J, Desquesnes A, Le Gonidec S, AlSaati T, Beau I, Lamant L, Meggetto F, Espinos E, Codogno P, Brousset P, Giuriato S.

Oncotarget. 2015 Oct 6;6(30):30149-64. doi: 10.18632/oncotarget.4999.

6.

Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth.

Hoareau-Aveilla C, Valentin T, Daugrois C, Quelen C, Mitou G, Quentin S, Jia J, Spicuglia S, Ferrier P, Ceccon M, Giuriato S, Gambacorti-Passerini C, Brousset P, Lamant L, Meggetto F.

J Clin Invest. 2015 Sep;125(9):3505-18. doi: 10.1172/JCI78488. Epub 2015 Aug 10.

7.

MicroRNA and ALK-positive anaplastic large cell lymphoma.

Hoareau-Aveilla C, Merkel O, Meggetto F.

Front Biosci (Schol Ed). 2015 Jun 1;7:217-25. Review.

PMID:
25961697
8.

Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study.

Kirzin S, Marisa L, Guimbaud R, De Reynies A, Legrain M, Laurent-Puig P, Cordelier P, Pradère B, Bonnet D, Meggetto F, Portier G, Brousset P, Selves J.

PLoS One. 2014 Aug 1;9(8):e103159. doi: 10.1371/journal.pone.0103159. eCollection 2014.

9.

Specific infiltration pattern of FOXP3+ regulatory T cells in chronic histiocytic intervillositis of unknown etiology.

Capuani C, Meggetto F, Duga I, Danjoux M, March M, Parant O, Brousset P, Aziza J.

Placenta. 2013 Feb;34(2):149-54. doi: 10.1016/j.placenta.2012.12.004. Epub 2012 Dec 25.

PMID:
23270880
10.

Inhibition of Rac controls NPM-ALK-dependent lymphoma development and dissemination.

Colomba A, Giuriato S, Dejean E, Thornber K, Delsol G, Tronchère H, Meggetto F, Payrastre B, Gaits-Iacovoni F.

Blood Cancer J. 2011 Jun;1(6):e21. doi: 10.1038/bcj.2011.19. Epub 2011 Jun 3.

11.

ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation.

Dejean E, Foisseau M, Lagarrigue F, Lamant L, Prade N, Marfak A, Delsol G, Giuriato S, Gaits-Iacovoni F, Meggetto F.

Blood. 2012 May 17;119(20):4698-707. doi: 10.1182/blood-2011-10-386011. Epub 2012 Mar 6.

PMID:
22394598
12.

Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.

Dejean E, Renalier MH, Foisseau M, Agirre X, Joseph N, de Paiva GR, Al Saati T, Soulier J, Desjobert C, Lamant L, Prósper F, Felsher DW, Cavaillé J, Prats H, Delsol G, Giuriato S, Meggetto F.

Leukemia. 2011 Dec;25(12):1882-90. doi: 10.1038/leu.2011.168. Epub 2011 Jul 22.

PMID:
21778999
13.

A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor.

Chabot S, Jabrane-Ferrat N, Bigot K, Tabiasco J, Provost A, Golzio M, Noman MZ, Giustiniani J, Bellard E, Brayer S, Aguerre-Girr M, Meggetto F, Giuriato S, Malecaze F, Galiacy S, Jaïs JP, Chose O, Kadouche J, Chouaib S, Teissié J, Abitbol M, Bensussan A, Le Bouteiller P.

J Exp Med. 2011 May 9;208(5):973-86. doi: 10.1084/jem.20100810. Epub 2011 Apr 11.

14.

MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression.

Desjobert C, Renalier MH, Bergalet J, Dejean E, Joseph N, Kruczynski A, Soulier J, Espinos E, Meggetto F, Cavaillé J, Delsol G, Lamant L.

Blood. 2011 Jun 16;117(24):6627-37. doi: 10.1182/blood-2010-09-301994. Epub 2011 Apr 6.

PMID:
21471522
15.

Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia.

Giuriato S, Foisseau M, Dejean E, Felsher DW, Al Saati T, Demur C, Ragab A, Kruczynski A, Schiff C, Delsol G, Meggetto F.

Blood. 2010 May 20;115(20):4061-70. doi: 10.1182/blood-2008-06-163386. Epub 2010 Mar 11.

PMID:
20223922
16.

Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway.

Faumont N, Le Clorennec C, Teira P, Goormachtigh G, Coll J, Canitrot Y, Cazaux C, Hoffmann JS, Brousset P, Delsol G, Feuillard J, Meggetto F.

Cancer Res. 2009 Jun 15;69(12):5177-85. doi: 10.1158/0008-5472.CAN-08-2866. Epub 2009 Jun 2.

17.

Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes.

Faumont N, Chanut A, Benard A, Cogne N, Delsol G, Feuillard J, Meggetto F.

Haematologica. 2009 Mar;94(3):355-63. doi: 10.3324/haematol.13269. Epub 2009 Feb 11.

18.

Human herpesvirus 8 infections in patients with immunodeficiencies.

Laurent C, Meggetto F, Brousset P.

Hum Pathol. 2008 Jul;39(7):983-93. doi: 10.1016/j.humpath.2008.02.010. Review.

PMID:
18570975
19.

Detection of different clonal EBV strains in Hodgkin lymphoma and nasopharyngeal carcinoma tissues from the same patient.

Rey J, Xerri L, Bouabdallah R, Keuppens M, Brousset P, Meggetto F.

Br J Haematol. 2008 Jul;142(1):79-81. doi: 10.1111/j.1365-2141.2008.07162.x. Epub 2008 Apr 16.

PMID:
18422778
20.

Follicular dendritic cell tumor of the spleen associated with diffuse large B-cell lymphoma.

Laurent C, Meggetto F, de Paiva GR, Selves J, Palasse J, Laurent G, Brousset P.

Hum Pathol. 2008 May;39(5):776-80. doi: 10.1016/j.humpath.2007.08.022. Epub 2008 Mar 4.

PMID:
18291441
21.

Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapy.

Giuriato S, Faumont N, Bousquet E, Foisseau M, Bibonne A, Moreau M, Al Saati T, Felsher DW, Delsol G, Meggetto F.

Cancer Biol Ther. 2007 Aug;6(8):1318-23. Epub 2007 May 29.

PMID:
17660712
22.

A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.

Bousquet M, Broccardo C, Quelen C, Meggetto F, Kuhlein E, Delsol G, Dastugue N, Brousset P.

Blood. 2007 Apr 15;109(8):3417-23. Epub 2006 Dec 19.

PMID:
17179230
23.

Contribution of microdissection for the detection of microsatellite instability in colorectal cancer.

Danjoux M, Guimbaud R, Al Saati T, Meggetto F, Carrère N, Portier G, Delsol G, Selves J.

Hum Pathol. 2006 Mar;37(3):361-8.

PMID:
16613332
24.

In Hodgkin's disease Reed-Sternberg cells and normal B-lymphocytes are infected by related Epstein-Barr virus strains.

Faumont N, Trempat P, Brousset P, Delsol G, Meggetto F.

Virus Res. 2004 May;101(2):163-73.

PMID:
15041184
25.

Acquisition of viral receptor by NK cells through immunological synapse.

Tabiasco J, Vercellone A, Meggetto F, Hudrisier D, Brousset P, Fournié JJ.

J Immunol. 2003 Jun 15;170(12):5993-8.

26.

Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus.

Trempat P, Tabiasco J, Andre P, Faumont N, Meggetto F, Delsol G, Gascoyne RD, Fournie JJ, Vivier E, Brousset P.

J Virol. 2002 Nov;76(21):11139-42.

27.

Human herpesvirus-8-associated lymphoma of the bowel in human immunodeficiency virus-positive patients without history of primary effusion lymphoma.

Costes V, Faumont N, Cesarman E, Rousset T, Meggetto F, Delsol G, Brousset P.

Hum Pathol. 2002 Aug;33(8):846-9.

PMID:
12203218
28.

Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.

Masy E, Adriaenssens E, Montpellier C, Crépieux P, Mougel A, Quatannens B, Goormachtigh G, Faumont N, Meggetto F, Auriault C, Groux H, Coll J.

J Virol. 2002 Jul;76(13):6460-72.

29.

A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice.

Gouble A, Grazide S, Meggetto F, Mercier P, Delsol G, Morello D.

Cancer Res. 2002 Mar 1;62(5):1489-95.

30.
31.

Demonstration by single-cell PCR that Reed--Sternberg cells and bystander B lymphocytes are infected by different Epstein--Barr virus strains in Hodgkin's disease.

Faumont N, Al Saati T, Brousset P, Offer C, Delsol G, Meggetto F.

J Gen Virol. 2001 May;82(Pt 5):1169-74.

PMID:
11297691
32.

Detection and characterization of human herpesvirus-8-infected cells in bone marrow biopsies of human immunodeficiency virus-positive patients.

Meggetto F, Cesarman E, Mourey L, Massip P, Delsol G, Brousset P.

Hum Pathol. 2001 Mar;32(3):288-91.

PMID:
11274637
34.

Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow biopsy from patients with multiple myeloma: PCR amplification of orf26 but not orf72 and orf75 sequences.

Brousset P, Meggetto F, Laharrague P, Attal M, Delsol.

Br J Haematol. 2000 Jan;108(1):197-8. No abstract available.

PMID:
10712004
35.

[Evidence for genetic abnormalities in Reed-Sternberg cells by PCR of cells isolated by micromanipulation ("single cell PCR")].

Delsol G, Faumont N, Caussinus E, al Saati T, Meggetto F.

Ann Pathol. 1999;19(5 Suppl):S6-9. French. No abstract available.

PMID:
10599451
36.

High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease.

Drouet E, Brousset P, Fares F, Icart J, Verniol C, Meggetto F, Schlaifer D, Desmorat-Coat H, Rigal-Huguet F, Niveleau A, Delsol G.

J Med Virol. 1999 Apr;57(4):383-9.

PMID:
10089051
37.

[New oncogenic viruses in human pathology].

Brousset P, Meggetto F, Delsol G.

Ann Pathol. 1998;18(5 Suppl):76-7. French. No abstract available.

PMID:
9884762
38.

[Importance of tumor banks in hemo-lymphatic pathology].

Delsol G, Lamant L, Meggetto F, Brousset P, al Saati T.

Ann Pathol. 1998;18(5 Suppl):27-32. Review. French. No abstract available.

PMID:
9884756
39.

Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma.

Brousset P, Meggetto F, Attal M, Delsol G.

Science. 1997 Dec 12;278(5345):1972; author reply 1972-3. No abstract available.

PMID:
9417645
41.

Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus.

Selves J, Meggetto F, Brousset P, Voigt JJ, Pradère B, Grasset D, Icart J, Mariamé B, Knecht H, Delsol G.

Am J Surg Pathol. 1996 Jun;20(6):747-53.

PMID:
8651355
42.

Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease.

Brousset P, Benharroch D, Krajewski S, Laurent G, Meggetto F, Rigal-Huguet F, Gopas J, Prinsloo I, Pris J, Delsol G, Reed JC, Schlaifer D.

Blood. 1996 Mar 15;87(6):2470-5.

PMID:
8630413
44.

Epstein-Barr virus latent and replicative gene expression in gastric carcinoma.

Selves J, Bibeau F, Brousset P, Meggetto F, Mazerolles C, Voigt JJ, Pradere B, Chiotasso P, Delsol G.

Histopathology. 1996 Feb;28(2):121-7.

PMID:
8834519
45.

High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining.

Lamant L, Meggetto F, al Saati T, Brugières L, de Paillerets BB, Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Rigal F, Schlaifer D, Shiuta M, Mori S, Delsol G.

Blood. 1996 Jan 1;87(1):284-91.

PMID:
8547653
46.

A novel antigen detected by the CBF.78 antibody further distinguishes anaplastic large cell lymphoma from Hodgkin's disease.

al Saati T, Tkaczuk J, Krissansen G, Print C, Pileri S, Ralfkiaer E, Grogan TM, Meggetto F, Delsol G.

Blood. 1995 Oct 1;86(7):2741-6.

PMID:
7670113
47.

Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture.

Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye JC.

Endocrinology. 1995 Apr;136(4):1523-9.

PMID:
7895662
48.

Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease.

Brousset P, Schlaifer D, Meggetto F, Bachmann E, Rothenberger S, Pris J, Delsol G, Knecht H.

Blood. 1994 Oct 15;84(8):2447-51.

PMID:
7919364
49.

Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.

Brousset P, Drouet E, Schlaifer D, Icart J, Payen C, Meggetto F, Marchou B, Massip P, Delsol G.

AIDS. 1994 May;8(5):583-90.

PMID:
7914731
50.

Lack of restricted T-cell receptor beta-chain variable region (V beta) usage of reactive T-lymphocytes in Hodgkin's disease.

Meggetto F, al Saati T, Rubin B, Delsol G.

Br J Haematol. 1994 Mar;86(3):524-32.

PMID:
8043434

Supplemental Content

Loading ...
Support Center